DECISIONS OF THE ANNUAL GENERAL MEETING OF OKMETIC OYJ

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DECISIONS OF THE ANNUAL GENERAL MEETING OF OKMETIC OYJ

OKMETIC OYJ  STOCK EXCHANGE RELEASE    9 APRIL 2014  AT 1.45 P.M. DECISIONS OF THE ANNUAL GENERAL MEETING OF OKMETIC OYJ The annual general meeting of Okmetic Oyj was held on 9 April 2014, at 10.00 a.m. in the auditorium of the Finnish Aviation Museum, address Tietotie 3, Vantaa, Finland. The annual general meeting adopted the annual accounts and the consolidated annual accounts for the financial year 2013 and discharged the company's management from liability. USE OF THE PROFIT SHOWN ON THE BALANCE SHEET AND PAYMENT OF DIVIDEND The annual general meeting decided, in accordance with the proposal of the board of directors, that no dividend shall be paid for the financial year 2013 and that the loss for the financial year of the parent company, 208,387.78 euro, shall be recorded to the company's retained earnings. ELECTION AND REMUNERATION OF THE MEMBERS OF THE BOARD OF DIRECTORS The annual general meeting decided that there will be five members on the company's board of directors. Mr. Hannu Martola, Ms. Mervi Paulasto-Kröckel, Mr. Mikko Puolakka, and Mr. Henri Österlund were re-elected as members of the board of directors, and Mr. Jan Lång was elected as a new board member, all until the end of the next annual general meeting.Mr. Jan Lång (born 1957, M.Sc. (Econ.)) is President and CEO of Ahlstrom Oyj since 2009. Before this he acted as President and CEO of Uponor Oyj and in various management positions at Huhtamäki Oyj. The board of directors elected Henri Österlund as its chairman and Jan Lång as its vice chairman in its organisation meeting held immediately after the annual general meeting. It was decided that the following annual remuneration shall be paid to the members of the board of directors: 40,000 euro to the chairman, 30,000 euro to the vice chairman, and 20,000 euro to each of the other board members. The annual remuneration will be paid in the company's shares and in cash for the part of taxes. Payment of the annual remuneration will be made as a one-time payment on 9 May 2014. The number of remuneration shares shall be determined according to the closing quotation of the company's share on 8 May 2014. In addition, it was decided that the board members will be paid meeting remuneration, amount of which is 750 euro/meeting for the chairman of the board and 500 euro/meeting for the other board members. ELECTION AND REMUNERATION OF THE AUDITOR Authorised Public Accountants PricewaterhouseCoopers Oy was re-elected as auditor of the company. PricewaterhouseCoopers Oy has announced that APA, Mr. Mikko Nieminen will be acting as principal auditor. It was decided that remuneration to the auditor shall be paid according to the auditor's reasonable invoice. AUTHORISATION OF THE BOARD OF DIRECTORS TO DECIDE ON THE REPURCHASE AND/OR ACCEPTANCE AS PLEDGE OF THE COMPANY'S OWN SHARES The annual general meeting authorised the board of directors to decide on the repurchase and/or acceptance as pledge of the company's own shares in one or more tranches as follows: The aggregate number of shares repurchased and/or accepted as pledge shall not exceed 1,728,750 shares, which represents approximately 10 percent of all the shares of the company. The company and its subsidiaries together cannot at any time own and/or hold as pledge more than 10 percent of all the company's registered shares. Only unrestricted equity can be used to repurchase the company's own shares under the authorisation. Own shares can be repurchased at a price determined by public trading on the day of repurchase or at another market-based price. The board of directors decides on the method of repurchasing and/or accepting as pledge of the company's own shares as well as the other terms and conditions. Shares can be repurchased otherwise than in the shareholders' proportional holding of shares (directed repurchase). The authorisation cancels the authorisation given by the annual general meeting on 10 April 2013 to the board of directors to decide on the repurchase and/or acceptance as a pledge of the company's own shares. The authorisation is effective until the next annual general meeting, however, no longer than until 9 October 2015. AUTHORISATION OF THE BOARD OF DIRECTORS TO DECIDE ON THE ISSUANCE OF SHARES, THE TRANSFER OF THE COMPANY'S OWN SHARES AS WELL AS THE ISSUANCE OF SPECIAL RIGHTS ENTITLING TO SHARES The annual general meeting authorised the board of directors to decide on the issuance of shares, the transfer of the company's own shares, and the issuance of special rights entitling to shares according to Chapter 10, Section 1 of the Finnish Companies Act in one or more tranches as follows: The aggregate number of shares issued or transferred on the basis of the authorisation may not exceed 2,593,125 shares. The board of directors decides on all the terms and conditions of the issuance of shares, the transfer of the company's own shares, and the issuance of special rights entitling to shares according to Chapter 10, Section 1 of the Finnish Companies Act. The authorisation concerns both the issuance of new shares as well as the transfer of the company's own shares. The issuance of shares, the transfer of the company's own shares, and the issuance of special rights entitling to shares according to Chapter 10, Section 1 of the Finnish Companies Act may be carried out in deviation from the shareholders' pre-emptive rights (directed issue). The authorisation cancels the authorisation given by the annual general meeting on 10 April 2013 to the board of directors to decide on the issuance of shares, the transfer of the company's own shares as well as the issuance of special rights entitling to shares. The authorisation is effective until the next annual general meeting, however, no longer than until 9 October 2015. OKMETIC OYJ Kai Seikku President For further information, please contact: Kai Seikku, President, Okmetic Oyj, Tel. +358 9 5028 0232, e-mail: kai.seikku@okmetic.com Juha Jaatinen, Senior Vice President, Finance, IT and Communications, Okmetic Oyj, tel. +358 5028 0286, e-mail: juha.jaatinen@okmetic.com Distribution: NASDAQ OMX Helsinki Ltd Principal media www.okmetic.fi OKMETIC IN BRIEF Okmetic is a technology company which supplies tailor-made silicon wafers for sensor and semiconductor industries and sells its technological expertise. Okmetic provides its customers with solutions that boost their competitiveness and profitability. Okmetic's silicon wafers are part of a further processing chain that produces end products that improve human interaction and quality of life. The company's products are based on high-tech expertise that generates added value for customers, innovative product development and an extremely efficient production process. Okmetic has a worldwide clientele and sales network, production plants in Finland and in the United States as well as license-based production in Japan and in China. Ocmetic's shares are listed on the NASDAQ OMX Helsinki Ltd under the trading symbol OKM1V. Additional information can be found on the company's website: www.okmetic.com. [HUG#1775893]

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 144

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 83

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 688

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 251

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 105

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 531

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 809

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 112

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 220

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 382

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Nutex Health Inc: Understanding Recent Legal Developments

Updated Category News Views 119

Overview of Nutex Health Inc. Nutex Health Inc. (NASDAQ: NUTX) is a key player in the healthcare sector, known for its innovative services and strategies aimed at enhancing patient care. As investors, it is crucial to stay informed about potential impacts to the company’s stock due to various legal challenges. Recent Legal Actions Recently, the law firm Kirby McInerney...

Continue Reading
Cyber Threats: 65% of Firms Fear Survival Risks

Updated Category News Views 18

A Wake-Up Call for Businesses If you thought the cyber threats were just a sideshow, think again. Sixty-five percent of businesses are tossing around the notion that a serious cyber attack could knock them out for good. Databarracks just unveiled its 2026 Data Health Check, airing out the gloomy stats we frankly can't ignore anymore. Cyber Attacks: More Than Just a...

Continue Reading
Understanding the Recent Supplementary Prospectus Release

Updated Category News Views 122

Overview of the Supplementary Prospectus Hargreave Hale AIM VCT plc has recently released a supplementary prospectus approved by the Financial Conduct Authority. This document is essential for investors seeking to understand recent developments regarding the company's financial situation. Purpose of the Supplementary Prospectus The supplementary prospectus is a regulatory...

Continue Reading
Carbliss Celebrates Launch in Arizona After Record Growth

Updated Category News Views 170

Carbliss Launches in Arizona: A Significant Expansion Carbliss has officially launched in Arizona, enhancing its reach and marking a pivotal point in the brand's journey. This premium ready-to-drink cocktail brand, known for its zero sugar, zero carb, and 100 calorie beverages, has made a notable impact in the beverage industry through a focus on quality and consumer...

Continue Reading
MicroStrategy's Bold Investment in Bitcoin Sparks Debate

Updated Category News Views 85

MicroStrategy's Bold Investment Strategies As the world watches Bitcoin prices soar to new heights, MicroStrategy's aggressive accumulation of Bitcoin has become a hot topic in the crypto community. Many traders and analysts are scrutinizing the company's strategy as it continues to amass significant Bitcoin holdings. Understanding Recent Developments Industry expert Alex...

Continue Reading